Press Releases

11/29/2018

New Studies Using CELLSEARCH Circulating Tumor Cell Test to be Featured at San Antonio Breast Cancer Symposium

Research Adds to Growing Evidence of Clinical Utility of CTCs for the management of Metastatic Breast Cancer Patients

continue →

Topics: CELLSEARCH, CTCs, Precision Medicine, metastatic breast cancer, Liquid biopsy

11/27/2018

Single-Cell Genomic Analysis of Blood Cancers to be Highlighted at American Society of Hematology Meeting

DEPArray Technology Used for Detection and Isolation of Lymphoma and Multiple Myeloma Cells

continue →

Topics: single-cell isolation, classical Hodgkin Lymphoma, Multiple myeloma, Reed-Sternberg (HRS) Cells, deparray, copy number alteration

05/30/2018

Circulating Tumor Cells to Help Stage Metastatic Breast Cancer, New Research To Be Featured at ASCO Annual Meeting

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., May 30, 2018 -- Menarini Silicon Biosystems announced today that a new study has found that using circulating tumor cells (CTCs), a form of liquid biopsy, holds promise as a key tool for developing a staging system that can have a significant impact in the treatment of metastatic breast cancer (MBC).

continue →

Topics: Circulating tumor cells, metastatic breast cancer

03/15/2018

Menarini Hires Their 17,000th Employee

The 17,000th employee in Menarini is Lara, 28 years old, a young graduate in Chemistry and Pharmaceutical Technology from the University of Florence, who is now employed in Menarini Ricerche.

continue →

Topics: menarini

03/12/2018

A robust method to study cancer heterogeneity in liquid biopsy

Copy Number Alteration Profiling of Single Circulating Tumor Cells which May Be used to Predict Response to Therapy

continue →

Topics: Liquid biopsy, CTCs, Precision Medicine, low-pass, copy number alteration, CELLSEARCH, DEPArray NxT, NGS

05/16/2017

Top International Experts Gather to Understand the Many Faces of Cancer

Second World Summit on Cancer Heterogeneity and Precision Medicine Meets in Washington

continue →

Topics: Cancer Heterogeneity, Liquid biopsy, CTCs, FFPE, International experts, International conference, Menarini International Foundation, Precision Medicine

04/3/2017

Menarini-Silicon Biosystems Completes Acquisition of CELLSEARCH® Assets

Liquid Biopsy Test for Circulating Tumor Cells Marks Its First Entry into U.S. Diagnostics Market

continue →

Topics: CELLSEARCH, acquisition, CTC test, CTCs, Liquid biopsy, deparray

12/20/2016

Menarini-Silicon Biosystems to Acquire CELLSEARCH® CTC System

Only FDA-Cleared CTC test to join Company’s Portfolio of Diagnostics

continue →

Topics: CTCs, CELLSEARCH, deparray, single-cell isolation

11/25/2016

DEPArray™ Single-Cell Isolation Technology Enables Researchers to Develop a Model for Predicting Response to Treatment in Patients with Lung Cancer

Genetic Profiles of Circulating Tumor Cells May Predict Drug Resistance and Clinical Outcomes

continue →

Topics: CTCs, lung cancer, deparray, SCLC

10/26/2016

Cancer Researchers Gather in Bologna for Menarini-Silicon Biosystem’s DEPArray™ User Meeting to Unravel the Secrets of Cancer

Single-Cell Isolation Technology Brings Vision of Personalized Cancer Treatment Closer to Reality

continue →
Ask Us a QuestionShare your DEPArray™ storySubscribe to newsletter